The company also focuses on providing solutions in the field of major diseases, especially oncology and rare diseases.Īfter this round of financing, LinkDoc will connect all kinds of online and offline resources to establish a service loop, and benefit more patients, based on its advantages in data management, auxiliary diagnosis and treatment, scientific research services, patient management, doctor operation, and drug distribution in the vertical field of oncology. At present, its main business includes real-world pharmaceutical researches, patient health management, patient recruitment, etc. ![]() The listing has already been approved by Nasdaq under the ticker ( LDOC). China extends probes of US-listed tech groups after curbs on Didi. initial public offering at the last minute. With the mission of "Care Data Care Life", LinkDoc provides the overall solution of big data and AI for all parties in the pharmaceutical and medical industry. The medical-data company LinkDoc Technology issued a prospectus on July 7 for a U.S. HONG KONG - Chinese medical data group LinkDoc Technology has called off its U.S. LinkDoc is committed to the R&D of big data and artificial intelligence (AI). This strategic investment in LinkDoc is Ali Health's new scheme in the field of major diseases, which demonstrates Ali Health's determination to promote medical care of serious diseases with innovative Internet technologies. Through the layout of "having good drugs, famous doctors and guarantee", Ali Health uses the Internet model and technological innovation to promote the development of scientific research, diagnosis and treatment of major diseases, genetic testing, biological vaccines, and other fields. With the "Internet + Medicine" strategy, Ali Health has established a reliable and inclusive medical service system. It was seen as raising as much as 211 million by selling 10.8 million shares priced. Under the background of encouraging the innovative development of medical and healthcare enterprises, Ali Health actively expands its business to meet the diversified medical and healthcare needs of more patients. LinkDoc, which filed for its IPO in June, was due to price its offering after the US market close on Thursday. The two companies will build a patient-centered and technological innovation-driven full-disease cycle service platform for Chinese oncology patients, actively explore innovative online service mode of oncology specialty drugs, and create an online and offline oncology specialty medical service system, to provide patients with high-quality medical services covering the entire disease cycle, from treatment to medicine. 4, 2021 - LinkDoc Technology ("LinkDoc"), a Chinese company focusing on big data in medicine, recently announced it has received a strategic investment from Ali Health. The sources declined to be named as the information has not yet been made public yet.īeijing-based LinkDoc did not immediately respond to a request for comment.(VCBeat) Mar. The book closed one day earlier than planned on Wednesday, two of the sources said. ![]() Its investors include Alibaba Health Information. The deal would have raised $211 million at the upper end of the indicated range. LinkDoc, founded in 2014, provides cancer focused health-care services built on big data and artificial intelligence, its website shows. ![]() The tougher position by the Cybersecurity Administration of China has been driven in part by concerns that the U.S. It had planned to sell 10.8 million shares between $17.50 and $19.50 each. LinkDoc’s decision to suspend its 211-million IPO is. LinkDoc filed for an initial public offering in the United States last month and was due to price its shares after the U.S. One of the sources said the regulatory uncertainty affected both the company and investors. The decision to pull the LinkDoc deal was due to the crackdown, the sources said. The next issue of Financial Post Top Stories will soon be in your inbox. According to Bloomberg, LinkDoc Technology Limited, a medical data platform company backed by Alibaba Group, plans to lead a 200 to 300 million financing round before its upcoming IPO in Hong Kong. If you don't see it, please check your junk folder.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |